中锐股份(002374) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue decreased by 48.90% to CNY 124,437,640.68 compared to the same period last year[8] - Net profit attributable to shareholders was a loss of CNY 13,884,563.22, a decrease of 5.50% compared to the same period last year[8] - Basic earnings per share were -CNY 0.0158, a decrease of 5.33% compared to the same period last year[8] - The weighted average return on net assets was -0.58%, a decrease of 0.04% compared to the same period last year[8] - The company reported a 192.33% decrease in net profit attributable to the parent company compared to the same period last year, primarily due to the significant drop in operating revenue[17] - Net loss for Q3 2020 was CNY 12,712,231.31, compared to a net loss of CNY 12,109,555.15 in the same period last year[45] - The net profit for the current period is a loss of CNY 620,375.05, compared to a loss of CNY 6,915,035.66 in the previous period, showing an improvement in financial performance[49] - The total comprehensive income for the current period is a loss of CNY 34,152,518.67, compared to a profit of CNY 36,365,218.36 in the previous period[53] Assets and Liabilities - Total assets increased by 4.47% to CNY 6,270,099,881.70 compared to the end of the previous year[8] - The total amount of major contracts signed by Chongqing Huayu Garden Co., Ltd. includes a PPP project with a total value of ¥456 million, with 97% completion and revenue recognized of ¥444.34 million[26] - The company reported a total current asset of ¥2.74 billion as of September 30, 2020, compared to ¥2.62 billion at the end of 2019, reflecting an increase of approximately 4.4%[34] - The total liabilities decreased to ¥3.27 billion from ¥3.43 billion, showing a decline of approximately 4.8%[37] - The company's long-term borrowings increased to ¥823 million from ¥595 million, reflecting a growth of approximately 38.4%[37] - The total liabilities amounted to ¥3,431,854,974.61, remaining unchanged from the previous reporting period[69] - The total assets of the company were reported at ¥6,001,618,751.90, consistent with the previous period[69] Cash Flow - Net cash flow from operating activities was a negative CNY 15,325,644.36, a decrease of 130.08% compared to the same period last year[8] - Cash and cash equivalents increased by 82.12% compared to the beginning of the year, mainly due to the successful fundraising from a targeted issuance[16] - The net increase in cash and cash equivalents rose by 155.06% compared to the previous year, mainly due to the successful fundraising[18] - Cash flow from operating activities shows a net inflow of ¥1,439,734.38, down from ¥24,950,043.11 in the previous period[60] - Total cash and cash equivalents at the end of the period amount to ¥615,503,381.90, an increase from ¥220,639,505.19 at the end of the previous period[61] - Cash outflow from financing activities was ¥1,187,077,909.76, down from ¥1,674,419,405.56 in the previous period[61] Shareholder Information - The total number of shareholders at the end of the reporting period was 30,309[12] - The largest shareholder, Suzhou Ruichang Investment Management Co., Ltd., held 11.98% of the shares[12] Cost Management - Total operating costs for Q3 2020 were CNY 134,849,854.75, down from CNY 253,961,596.06 year-on-year[44] - The total operating costs for the year-to-date period are CNY 415,249,283.81, down from CNY 739,623,358.21 in the previous year, suggesting effective cost control measures[51] - Operating costs for the current period are CNY 54,706,652.78, down from CNY 72,618,854.99 previously, indicating a cost reduction strategy[48] Investment and Financing - The company raised a total of RMB 479,999,998.20 through a non-public stock issuance at a price of RMB 2.28 per share[19] - The company received cash from financing activities totaling ¥1,513,376,013.73, compared to ¥1,803,714,500.00 in the previous period[61] - The company received ¥471,545,598.24 from investment absorption, with no previous amount reported for comparison[64] Research and Development - Research and development expenses for the current period are CNY 117,103.66, indicating ongoing investment in innovation[48] - The company’s research and development expenses for the current period are ¥355,518.99, indicating ongoing investment in innovation[55] Financial Management - Financial expenses decreased by 163.43% year-on-year, mainly due to a reduction in financing scale and costs[16] - The company's financial expenses showed a significant improvement, with a net financial income of CNY -7,321,995.66 compared to CNY 2,997,677.60 in the previous period[44] - Financial expenses have decreased significantly to CNY -12,330,789.66 from CNY 19,439,120.36 in the previous period, reflecting improved financial management[52] - The company reported a credit impairment loss of CNY 2,104,105.15, a significant decrease from CNY 60,432,808.59 in the previous period, indicating better asset quality[52] Inventory and Receivables - The company’s inventory decreased by 72.19% compared to the beginning of the year, as inventory was reclassified to contract assets[16] - Accounts receivable decreased to ¥1.28 billion from ¥1.43 billion, indicating a reduction of about 10.2%[34] - The company’s receivables financing decreased by 44.13% compared to the beginning of the year, due to a reduction in the amount of negotiable bills available for endorsement[16]